Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OmniAb, Inc. | 40,000 | reported | 17 Jun 2026 | tx 23+768,465−113,308 |
| ELI LILLY & Co | 6,243 | reported | 16 Nov 2020 | tx 4+6,053 |
| ALNYLAM PHARMACEUTICALS, INC. | 775 | reported | 08 May 2025 | tx 4+11,829 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2026 | EXERCISE | OmniAb, Inc. | 20,000 | — | |
| 17 Jun 2026 | EXERCISE | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 17 Jun 2026 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 17 Jun 2026 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 01 Nov 2025 | EXERCISE | OmniAb, Inc. | 17,769 | — | |
| 01 Nov 2025 | EXERCISE | OmniAb, Inc. | 17,769 | 0.00 USD | deriv |
| 17 Jun 2025 | EXERCISE | OmniAb, Inc. | 20,000 | — | |
| 17 Jun 2025 | EXERCISE | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 08 May 2025 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 775 | 0.00 USD | |
| 08 May 2025 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,558 | 0.00 USD | deriv |
| 01 Nov 2024 | EXERCISE | OmniAb, Inc. | 17,769 | — | |
| 01 Nov 2024 | EXERCISE | OmniAb, Inc. | 17,769 | 0.00 USD | deriv |
| 18 Jun 2024 | EXERCISE | OmniAb, Inc. | 20,000 | — | |
| 18 Jun 2024 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 18 Jun 2024 | EXERCISE | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 5,228 | 0.00 USD | deriv |
| 01 Nov 2023 | EXERCISE | OmniAb, Inc. | 17,770 | — | |
| 01 Nov 2023 | EXERCISE | OmniAb, Inc. | 17,770 | — | deriv |
| 23 Jun 2023 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 05 Jan 2023 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4,268 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | OmniAb, Inc. | 53,308 | 0.00 USD |